ZPD A/S: Financial statements 2025
CVR: 32834825
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
ZPD A/S (CVR 32834825) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 52,704,000 and a net result of DKK 10,220,000 compared with DKK 12,864,000 the year before. That is an increase of 6.9% compared with the year before. Equity in the 2025 report amounted to DKK 217,641,000. The solvency ratio was 92.2%. The company had 39 employees in the financial year.
- Gross Profit
- DKK 52,704,000
- Profit/Loss
- DKK 10,220,000
- Equity
- DKK 217,641,000
- Total Assets
- DKK 236,052,000
- Employees
- 39
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 52.7 mio. | 10.2 mio. | 217.6 mio. | 39 |
| 2024 | - | 49.3 mio. | 12.9 mio. | 208.9 mio. | 35 |
| 2023 | - | 43.8 mio. | 11.8 mio. | 197.1 mio. | 35 |
| 2022 | - | 37.3 mio. | 7.1 mio. | 185.2 mio. | 35 |
| 2021 | - | 35.2 mio. | 7 mio. | 178.2 mio. | 36 |
Official annual report
How creditworthy is ZPD A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
ZPD A/S has published its annual report for 2024. Gross profit came to DKK 49,315,000, and the net result was DKK 12,864,000.
About ZPD A/S
ZPD A/S is a Danish company of the type Aktieselskab based in Esbjerg, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named BIOFAC ESBJERG A/S. The management consists of Frank Marek and Hiroyuki Shinya. The board consists of Masakazu Sakurai (chair), Frank Marek and Ken Motegi. The company is owned by Zeria Pharmaceutical Co. Ltd.. The company has 54 employees (2026). In 2025, the company reported a gross profit of DKK 52,704,000 and a net result of DKK 10,220,000 compared with DKK 12,864,000 the year before. Equity in the 2025 report amounted to DKK 217,641,000.